{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T23:43:58Z","timestamp":1773445438863,"version":"3.50.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Joint Funds for the Innovation of Science and Technology, Fujian province, China","award":["2019Y9131"],"award-info":[{"award-number":["2019Y9131"]}]},{"name":"the Joint Funds for the Innovation of Science and Technology, Fujian province, China","award":["2019Y9131"],"award-info":[{"award-number":["2019Y9131"]}]},{"name":"the Joint Funds for the Innovation of Science and Technology, Fujian province, China","award":["2019Y9131"],"award-info":[{"award-number":["2019Y9131"]}]},{"name":"the Joint Funds for the Innovation of Science and Technology, Fujian province, China","award":["2019Y9131"],"award-info":[{"award-number":["2019Y9131"]}]},{"name":"the Joint Funds for the Innovation of Science and Technology, Fujian province, China","award":["2019Y9131"],"award-info":[{"award-number":["2019Y9131"]}]},{"name":"the Joint Funds for the Innovation of Science and Technology, Fujian province, China","award":["2019Y9131"],"award-info":[{"award-number":["2019Y9131"]}]},{"name":"the Joint Funds for the Innovation of Science and Technology, Fujian province, China","award":["2019Y9131"],"award-info":[{"award-number":["2019Y9131"]}]},{"name":"the Joint Funds for the Innovation of Science and Technology, Fujian province, China","award":["2019Y9131"],"award-info":[{"award-number":["2019Y9131"]}]},{"name":"the Startup Fund for scientific research, Fujian Medical University","award":["2022QH2038"],"award-info":[{"award-number":["2022QH2038"]}]},{"name":"the Startup Fund for scientific research, Fujian Medical University","award":["2022QH2038"],"award-info":[{"award-number":["2022QH2038"]}]},{"name":"the Startup Fund for scientific research, Fujian Medical University","award":["2022QH2038"],"award-info":[{"award-number":["2022QH2038"]}]},{"name":"the Startup Fund for scientific research, Fujian Medical University","award":["2022QH2038"],"award-info":[{"award-number":["2022QH2038"]}]},{"name":"the Startup Fund for scientific research, Fujian Medical University","award":["2022QH2038"],"award-info":[{"award-number":["2022QH2038"]}]},{"name":"the Startup Fund for scientific research, Fujian Medical University","award":["2022QH2038"],"award-info":[{"award-number":["2022QH2038"]}]},{"name":"the Startup Fund for scientific research, Fujian Medical University","award":["2022QH2038"],"award-info":[{"award-number":["2022QH2038"]}]},{"name":"the Startup Fund for scientific research, Fujian Medical University","award":["2022QH2038"],"award-info":[{"award-number":["2022QH2038"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-77294-w","type":"journal-article","created":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T18:02:57Z","timestamp":1730743377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Curcumin derivative C210 induces Epstein\u2013Barr virus lytic cycle and inhibits virion production by disrupting Hsp90 function"],"prefix":"10.1038","volume":"14","author":[{"given":"Linli","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suling","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengnan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,4]]},"reference":[{"key":"77294_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2014.82","volume":"47","author":"CY Ok","year":"2015","unstructured":"Ok, C. Y., Li, L. & Young, K. H. EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management. Exp Mol Med47, e132 (2015).","journal-title":"Exp Mol Med"},{"key":"77294_CR2","doi-asserted-by":"publisher","first-page":"17378","DOI":"10.3390\/ijms140917378","volume":"14","author":"RW-M Lung","year":"2013","unstructured":"Lung, R.W.-M., Tong, J.H.-M. & To, K.-F. Emerging roles of small Epstein-Barr virus derived non-coding RNAs in epithelial malignancy. Int J Mol Sci14, 17378\u201317409 (2013).","journal-title":"Int J Mol Sci"},{"key":"77294_CR3","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1111\/cas.14381","volume":"111","author":"T Lu","year":"2020","unstructured":"Lu, T. et al. Circulating Epstein-Barr virus microRNAs BART7-3p and BART13-3p as novel biomarkers in nasopharyngeal carcinoma. Cancer Sci111, 1711\u20131723 (2020).","journal-title":"Cancer Sci"},{"key":"77294_CR4","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.cellbi.2008.03.022","volume":"32","author":"S-F Liu","year":"2008","unstructured":"Liu, S.-F. et al. NF-kappaB inhibitors induce lytic cytotoxicity in Epstein-Barr virus-positive nasopharyngeal carcinoma cells. Cell Biol Int32, 1006\u20131013 (2008).","journal-title":"Cell Biol Int"},{"key":"77294_CR5","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1002\/ijc.27439","volume":"131","author":"KF Hui","year":"2012","unstructured":"Hui, K. F. et al. Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma. Int. J. Cancer131, 1930\u20131940 (2012).","journal-title":"Int. J. Cancer"},{"key":"77294_CR6","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.canlet.2016.04.001","volume":"376","author":"Y Du","year":"2016","unstructured":"Du, Y., Yu, J., Du, L., Tang, J. & Feng, W.-H. Cordycepin enhances Epstein-Barr virus lytic infection and Epstein-Barr virus-positive tumor treatment efficacy by doxorubicin. Cancer Lett376, 240\u2013248 (2016).","journal-title":"Cancer Lett"},{"key":"77294_CR7","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1128\/AAC.45.7.2082-2091.2001","volume":"45","author":"SM Moore","year":"2001","unstructured":"Moore, S. M., Cannon, J. S., Tanhehco, Y. C., Hamzeh, F. M. & Ambinder, R. F. Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues. Antimicrob Agents Chemother45, 2082\u20132091 (2001).","journal-title":"Antimicrob Agents Chemother"},{"key":"77294_CR8","doi-asserted-by":"publisher","first-page":"6297","DOI":"10.1182\/blood-2011-01-332379","volume":"117","author":"CM Shirley","year":"2011","unstructured":"Shirley, C. M. et al. Bortezomib induction of C\/EBP\u03b2 mediates Epstein-Barr virus lytic activation in Burkitt lymphoma. Blood117, 6297\u20136303 (2011).","journal-title":"Blood"},{"key":"77294_CR9","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/annonc\/mdv596","volume":"27","author":"SJ Kim","year":"2016","unstructured":"Kim, S. J. et al. Epstein-Barr virus reactivation in extranodal natural killer\/T-cell lymphoma patients: a previously unrecognized serious adverse event in a pilot study with romidepsin. Ann Oncol27, 508\u2013513 (2016).","journal-title":"Ann Oncol"},{"key":"77294_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007179","volume":"14","author":"JA Bristol","year":"2018","unstructured":"Bristol, J. A. et al. A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection. PLoS Pathog14, e1007179 (2018).","journal-title":"PLoS Pathog"},{"key":"77294_CR11","doi-asserted-by":"publisher","first-page":"7976","DOI":"10.1128\/JVI.00770-12","volume":"86","author":"S-D Ma","year":"2012","unstructured":"Ma, S.-D. et al. An Epstein-Barr Virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model. J Virol86, 7976\u20137987 (2012).","journal-title":"J Virol"},{"key":"77294_CR12","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1097\/MIB.0000000000000522","volume":"21","author":"R-MT McFadden","year":"2015","unstructured":"McFadden, R.-M.T. et al. The role of curcumin in modulating colonic microbiota during colitis and colon cancer prevention. Inflamm Bowel Dis21, 2483\u20132494 (2015).","journal-title":"Inflamm Bowel Dis"},{"key":"77294_CR13","first-page":"673","volume":"26","author":"C-Y Cheng","year":"2010","unstructured":"Cheng, C.-Y., Lin, Y.-H. & Su, C.-C. Curcumin inhibits the proliferation of human hepatocellular carcinoma J5 cells by inducing endoplasmic reticulum stress and mitochondrial dysfunction. Int J Mol Med26, 673\u2013678 (2010).","journal-title":"Int J Mol Med"},{"key":"77294_CR14","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.1021\/jm401352a","volume":"57","author":"K-L Tan","year":"2014","unstructured":"Tan, K.-L. et al. Synthesis and evaluation of bisbenzylidenedioxotetrahydrothiopranones as activators of endoplasmic reticulum (ER) stress signaling pathways and apoptotic cell death in acute promyelocytic leukemic cells. J Med Chem57, 5904\u20135918 (2014).","journal-title":"J Med Chem"},{"key":"77294_CR15","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.3390\/ijms18102105","volume":"18","author":"GJ Szebeni","year":"2017","unstructured":"Szebeni, G. J. et al. achiral mannich-base curcumin analogs induce unfolded protein response and mitochondrial membrane depolarization in PANC-1 cells. Int J Mol Sci18, 2105 (2017).","journal-title":"Int J Mol Sci"},{"key":"77294_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/cancers10040089","volume":"10","author":"O Ramayanti","year":"2018","unstructured":"Ramayanti, O. et al. Curcuminoids as EBV lytic activators for adjuvant treatment in EBV-positive carcinomas. Cancers10, 89 (2018).","journal-title":"Cancers"},{"key":"77294_CR17","doi-asserted-by":"crossref","unstructured":"Lee et al_2019_Pharmacologic Activation of Lytic Epstein-Barr Virus Gene Expression without.pdf.","DOI":"10.1128\/JVI.00998-19"},{"key":"77294_CR18","doi-asserted-by":"publisher","first-page":"927","DOI":"10.4155\/fmc.12.50","volume":"4","author":"Z Nahleh","year":"2012","unstructured":"Nahleh, Z., Tfayli, A., Najm, A., El Sayed, A. & Nahle, Z. Heat shock proteins in cancer: Targeting the \u2018chaperones\u2019. Future Med Chem4, 927\u2013935 (2012).","journal-title":"Future Med Chem"},{"key":"77294_CR19","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nrc1716","volume":"5","author":"L Whitesell","year":"2005","unstructured":"Whitesell, L. & Lindquist, S. L. HSP90 and the chaperoning of cancer. Nat Rev Cancer5, 761\u2013772 (2005).","journal-title":"Nat Rev Cancer"},{"key":"77294_CR20","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1073\/pnas.0910717107","volume":"107","author":"X Sun","year":"2010","unstructured":"Sun, X. et al. Hsp90 inhibitors block outgrowth of EBV-infected malignant cells in vitro and in vivo through an EBNA1-dependent mechanism. Proc. Natl. Acad. Sci. U.S.A.107, 3146\u20133151 (2010).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"77294_CR21","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1080\/10428194.2016.1213823","volume":"58","author":"A Shatzer","year":"2017","unstructured":"Shatzer, A. et al. Ganetespib, an HSP90 inhibitor, kills Epstein-Barr virus (EBV)-infected B and T cells and reduces the percentage of EBV-infected cells in the blood. Leukemia Lymphoma58, 923\u2013931 (2017).","journal-title":"Leukemia Lymphoma"},{"key":"77294_CR22","doi-asserted-by":"publisher","first-page":"10126","DOI":"10.1128\/JVI.01671-13","volume":"87","author":"X Sun","year":"2013","unstructured":"Sun, X. et al. Hsp90 inhibitor 17-DMAG decreases expression of conserved herpesvirus protein kinases and reduces virus production in Epstein-Barr virus-infected cells. J Virol87, 10126\u201310138 (2013).","journal-title":"J Virol"},{"key":"77294_CR23","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/j.1745-7254.2006.00326.x","volume":"27","author":"L-X Wu","year":"2006","unstructured":"Wu, L.-X. et al. Down-regulation of p210(bcr\/abl) by curcumin involves disrupting molecular chaperone functions of Hsp90. Acta Pharmacol Sin27, 694\u2013699 (2006).","journal-title":"Acta Pharmacol Sin"},{"key":"77294_CR24","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/aps.2017.160","volume":"39","author":"Y-J Fan","year":"2018","unstructured":"Fan, Y.-J. et al. C1206, a novel curcumin derivative, potently inhibits Hsp90 and human chronic myeloid leukemia cells in vitro. Acta Pharmacol Sin39, 649\u2013658 (2018).","journal-title":"Acta Pharmacol Sin"},{"key":"77294_CR25","doi-asserted-by":"publisher","first-page":"15364","DOI":"10.18632\/oncotarget.14970","volume":"8","author":"M Ye","year":"2017","unstructured":"Ye, M. et al. FM807, a curcumin analogue, shows potent antitumor effects in nasopharyngeal carcinoma cells by heat shock protein 90 inhibition. Oncotarget8, 15364\u201315376 (2017).","journal-title":"Oncotarget"},{"key":"77294_CR26","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1158\/1078-0432.CCR-13-3317","volume":"21","author":"L Wu","year":"2015","unstructured":"Wu, L. et al. Dual inhibition of Bcr-Abl and Hsp90 by C086 potently inhibits the proliferation of imatinib-resistant CML cells. Clin Cancer Res21, 833\u2013843 (2015).","journal-title":"Clin Cancer Res"},{"key":"77294_CR27","doi-asserted-by":"publisher","first-page":"993","DOI":"10.2174\/1570180811666140512221037","volume":"11","author":"Y Liu","year":"2014","unstructured":"Liu, Y., Ye, M., Wu, Q., Wu, L. & Xu, J. Synthesis and evaluation of 4-arylmethyl curcumin analgues as potent Hsp90 inhibitors. LDDD11, 993\u2013999 (2014).","journal-title":"LDDD"},{"key":"77294_CR28","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/iub.607","volume":"64","author":"E Prinsloo","year":"2012","unstructured":"Prinsloo, E., Kramer, A. H., Edkins, A. L. & Blatch, G. L. STAT3 interacts directly with Hsp90. IUBMB Life64, 266\u2013273 (2012).","journal-title":"IUBMB Life"},{"key":"77294_CR29","doi-asserted-by":"publisher","first-page":"11438","DOI":"10.1128\/JVI.01762-13","volume":"87","author":"ER Hill","year":"2013","unstructured":"Hill, E. R. et al. Signal transducer and activator of transcription 3 limits Epstein-Barr virus lytic activation in B lymphocytes. J Virol87, 11438\u201311446 (2013).","journal-title":"J Virol"},{"key":"77294_CR30","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.1128\/JVI.00121-15","volume":"89","author":"S Koganti","year":"2015","unstructured":"Koganti, S. et al. Cellular STAT3 functions via PCBP2 to restrain Epstein-Barr virus lytic activation in B lymphocytes. J Virol89, 5002\u20135011 (2015).","journal-title":"J Virol"},{"key":"77294_CR31","doi-asserted-by":"crossref","unstructured":"Kwok Fung Lo, A. et al. Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells. Neoplasia8, 173\u2013180 (2006).","DOI":"10.1593\/neo.05625"},{"key":"77294_CR32","doi-asserted-by":"publisher","first-page":"6324","DOI":"10.1128\/JVI.74.14.6324-6332.2000","volume":"74","author":"SJ Molesworth","year":"2000","unstructured":"Molesworth, S. J., Lake, C. M., Borza, C. M., Turk, S. M. & Hutt-Fletcher, L. M. Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells. J Virol74, 6324\u20136332 (2000).","journal-title":"J Virol"},{"key":"77294_CR33","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41401-021-00642-3","volume":"43","author":"AAA Abdelmoaty","year":"2022","unstructured":"Abdelmoaty, A. A. A. et al. C0818, a novel curcumin derivative, induces ROS-dependent cytotoxicity in human hepatocellular carcinoma cells in vitro via disruption of Hsp90 function. Acta Pharmacol Sin43, 446\u2013456 (2022).","journal-title":"Acta Pharmacol Sin"},{"key":"77294_CR34","doi-asserted-by":"publisher","first-page":"e00998","DOI":"10.1128\/JVI.00998-19","volume":"93","author":"J Lee","year":"2019","unstructured":"Lee, J. et al. Pharmacologic activation of lytic Epstein-Barr virus gene expression without virion production. J Virol93, e00998-e1019 (2019).","journal-title":"J Virol"},{"key":"77294_CR35","doi-asserted-by":"publisher","first-page":"5424411","DOI":"10.1155\/2022\/5424411","volume":"2022","author":"Z Xiu","year":"2022","unstructured":"Xiu, Z. et al. Curcumin enhanced ionizing radiation-induced immunogenic cell death in glioma cells through endoplasmic reticulum stress signaling pathways. Oxid Med Cell Longev2022, 5424411 (2022).","journal-title":"Oxid Med Cell Longev"},{"key":"77294_CR36","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41580-020-0250-z","volume":"21","author":"C Hetz","year":"2020","unstructured":"Hetz, C., Zhang, K. & Kaufman, R. J. Mechanisms, regulation and functions of the unfolded protein response. Nat Rev Mol Cell Biol21, 421\u2013438 (2020).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"77294_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-016-0310-z","volume":"24","author":"X Yan","year":"2017","unstructured":"Yan, X. et al. Inhibition of histone acetylation by curcumin reduces alcohol-induced fetal cardiac apoptosis. J Biomed Sci24, 1 (2017).","journal-title":"J Biomed Sci"},{"key":"77294_CR38","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1128\/JVI.02393-15","volume":"90","author":"J Thompson","year":"2016","unstructured":"Thompson, J., Verma, D., Li, D., Mosbruger, T. & Swaminathan, S. Identification and characterization of the physiological gene targets of the essential lytic replicative Epstein-Barr virus SM protein. J Virol90, 1206\u20131221 (2016).","journal-title":"J Virol"},{"key":"77294_CR39","doi-asserted-by":"publisher","first-page":"4058","DOI":"10.1128\/JVI.02665-06","volume":"81","author":"Z Han","year":"2007","unstructured":"Han, Z. et al. Multiple roles of Epstein-Barr virus SM protein in lytic replication. J Virol81, 4058\u20134069 (2007).","journal-title":"J Virol"},{"key":"77294_CR40","doi-asserted-by":"publisher","first-page":"13044","DOI":"10.1073\/pnas.2000625117","volume":"117","author":"D Verma","year":"2020","unstructured":"Verma, D., Church, T. M. & Swaminathan, S. Epstein-Barr virus co-opts TFIIH component XPB to specifically activate essential viral lytic promoters. Proc. Natl. Acad. Sci. U.S.A.117, 13044\u201313055 (2020).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"77294_CR41","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.1158\/1078-0432.CCR-12-0574","volume":"18","author":"MA Wildeman","year":"2012","unstructured":"Wildeman, M. A. et al. Cytolytic virus activation therapy for Epstein-Barr virus-driven tumors. Clinical Cancer Research18, 5061\u20135070 (2012).","journal-title":"Clinical Cancer Research"},{"key":"77294_CR42","doi-asserted-by":"publisher","first-page":"7892","DOI":"10.1128\/JVI.00379-10","volume":"84","author":"Z Lin","year":"2010","unstructured":"Lin, Z. et al. Differential expression of the miR-200 family MicroRNAs in epithelial and B cells and regulation of Epstein-Barr virus reactivation by the miR-200 family member miR-429. J Virol84, 7892\u20137897 (2010).","journal-title":"J Virol"},{"key":"77294_CR43","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0092-8674(01)00611-0","volume":"107","author":"H Yoshida","year":"2001","unstructured":"Yoshida, H., Matsui, T., Yamamoto, A., Okada, T. & Mori, K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell107, 881\u2013891 (2001).","journal-title":"Cell"},{"key":"77294_CR44","doi-asserted-by":"publisher","first-page":"13566","DOI":"10.1128\/JVI.01055-07","volume":"81","author":"CC Sun","year":"2007","unstructured":"Sun, C. C. & Thorley-Lawson, D. A. Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter. J Virol81, 13566\u201313577 (2007).","journal-title":"J Virol"},{"key":"77294_CR45","doi-asserted-by":"publisher","first-page":"7363","DOI":"10.1128\/JVI.00154-07","volume":"81","author":"PM Bhende","year":"2007","unstructured":"Bhende, P. M., Dickerson, S. J., Sun, X., Feng, W.-H. & Kenney, S. C. X-box-binding protein 1 activates lytic Epstein-Barr virus gene expression in combination with protein kinase D. J Virol81, 7363\u20137370 (2007).","journal-title":"J Virol"},{"key":"77294_CR46","doi-asserted-by":"crossref","unstructured":"Verza, F. A., Das, U., Fachin, A. L., Dimmock, J. R. & Marins, M. Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy. Cancers (Basel)12, 1664 (2020).","DOI":"10.3390\/cancers12061664"},{"key":"77294_CR47","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s12012-013-9240-0","volume":"14","author":"H Sun","year":"2014","unstructured":"Sun, H., Zhu, J., Lu, T., Huang, X. & Tian, J. Curcumin-mediated cardiac defects in mouse is associated with a reduced histone H3 acetylation and reduced expression of cardiac transcription factors. Cardiovasc Toxicol14, 162\u2013169 (2014).","journal-title":"Cardiovasc Toxicol"},{"key":"77294_CR48","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.2217\/fmb.15.82","volume":"10","author":"KE Hanson","year":"2015","unstructured":"Hanson, K. E. & Swaminathan, S. Cytomegalovirus antiviral drug resistance: future prospects for prevention, detection and management. Future Microbiol10, 1545\u20131548 (2015).","journal-title":"Future Microbiol"},{"key":"77294_CR49","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/mc.20170","volume":"45","author":"CS Divya","year":"2006","unstructured":"Divya, C. S. & Pillai, M. R. Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis. Mol Carcinog45, 320\u2013332 (2006).","journal-title":"Mol Carcinog"},{"key":"77294_CR50","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1073\/pnas.90.5.1839","volume":"90","author":"CJ Li","year":"1993","unstructured":"Li, C. J., Zhang, L. J., Dezube, B. J., Crumpacker, C. S. & Pardee, A. B. Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication. Proc. Natl. Acad. Sci. U.S.A.90, 1839\u20131842 (1993).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"77294_CR51","doi-asserted-by":"publisher","first-page":"5829","DOI":"10.1111\/febs.12503","volume":"280","author":"J-L Ou","year":"2013","unstructured":"Ou, J.-L. et al. Structure-activity relationship analysis of curcumin analogues on anti-influenza virus activity. FEBS J280, 5829\u20135840 (2013).","journal-title":"FEBS J"},{"key":"77294_CR52","first-page":"1935","volume":"5","author":"K Zandi","year":"2010","unstructured":"Zandi, K. et al. Evaluation of antiviral activities of curcumin derivatives against HSV-1 in Vero cell line. Nat Prod Commun5, 1935\u20131938 (2010).","journal-title":"Nat Prod Commun"},{"key":"77294_CR53","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jep.2009.04.046","volume":"124","author":"HJ Kim","year":"2009","unstructured":"Kim, H. J. et al. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication. J Ethnopharmacol124, 189\u2013196 (2009).","journal-title":"J Ethnopharmacol"},{"key":"77294_CR54","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/ng1385","volume":"36","author":"JA Ranish","year":"2004","unstructured":"Ranish, J. A. et al. Identification of TFB5, a new component of general transcription and DNA repair factor IIH. Nat Genet36, 707\u2013713 (2004).","journal-title":"Nat Genet"},{"key":"77294_CR55","doi-asserted-by":"crossref","unstructured":"Egly, J. M. The 14th Datta Lecture. TFIIH: From transcription to clinic. FEBS Lett. 498, 124\u2013128 (2001).","DOI":"10.1016\/S0014-5793(01)02458-9"},{"key":"77294_CR56","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1073\/pnas.1523686113","volume":"113","author":"D Verma","year":"2016","unstructured":"Verma, D., Thompson, J. & Swaminathan, S. Spironolactone blocks Epstein-Barr virus production by inhibiting EBV SM protein function. Proc Natl Acad Sci U S A113, 3609\u20133614 (2016).","journal-title":"Proc Natl Acad Sci U S A"},{"key":"77294_CR57","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.cell.2012.06.047","volume":"150","author":"M Taipale","year":"2012","unstructured":"Taipale, M. et al. Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. Cell150, 987\u20131001 (2012).","journal-title":"Cell"},{"key":"77294_CR58","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s00294-005-0580-6","volume":"47","author":"G Flom","year":"2005","unstructured":"Flom, G., Weekes, J. & Johnson, J. L. Novel interaction of the Hsp90 chaperone machine with Ssl2, an essential DNA helicase in Saccharomyces cerevisiae. Curr Genet47, 368\u2013380 (2005).","journal-title":"Curr Genet"},{"key":"77294_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063566","volume":"8","author":"T Murata","year":"2013","unstructured":"Murata, T. et al. Heat shock protein 90 inhibitors repress latent membrane protein 1 (LMP1) expression and proliferation of Epstein-Barr virus-positive natural killer cell lymphoma. PLoS One8, e63566 (2013).","journal-title":"PLoS One"},{"key":"77294_CR60","doi-asserted-by":"publisher","first-page":"6482","DOI":"10.1128\/JVI.03428-12","volume":"87","author":"D Kawashima","year":"2013","unstructured":"Kawashima, D. et al. Nuclear transport of Epstein-Barr virus DNA polymerase is dependent on the BMRF1 polymerase processivity factor and molecular chaperone Hsp90. J Virol87, 6482\u20136491 (2013).","journal-title":"J Virol"},{"key":"77294_CR61","doi-asserted-by":"publisher","first-page":"10740","DOI":"10.1128\/JVI.79.16.10740-10749.2005","volume":"79","author":"AD Burch","year":"2005","unstructured":"Burch, A. D. & Weller, S. K. Herpes simplex virus type 1 DNA polymerase requires the mammalian chaperone hsp90 for proper localization to the nucleus. J Virol79, 10740\u201310749 (2005).","journal-title":"J Virol"},{"key":"77294_CR62","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1128\/jvi.63.4.1729-1736.1989","volume":"63","author":"S Kenney","year":"1989","unstructured":"Kenney, S. et al. The Epstein-Barr virus (EBV) BZLF1 immediate-early gene product differentially affects latent versus productive EBV promoters. J Virol63, 1729\u20131736 (1989).","journal-title":"J Virol"},{"key":"77294_CR63","doi-asserted-by":"publisher","first-page":"13993","DOI":"10.1128\/JVI.79.22.13993-14003.2005","volume":"79","author":"GK Hong","year":"2005","unstructured":"Hong, G. K. et al. Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model. J Virol79, 13993\u201314003 (2005).","journal-title":"J Virol"},{"key":"77294_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001236","volume":"6","author":"M Kvansakul","year":"2010","unstructured":"Kvansakul, M. et al. Structural basis for apoptosis inhibition by Epstein-Barr virus BHRF1. PLoS Pathog6, e1001236 (2010).","journal-title":"PLoS Pathog"},{"key":"77294_CR65","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nsmb.2367","volume":"19","author":"J Elegheert","year":"2012","unstructured":"Elegheert, J. et al. Allosteric competitive inactivation of hematopoietic CSF-1 signaling by the viral decoy receptor BARF1. Nat Struct Mol Biol19, 938\u2013947 (2012).","journal-title":"Nat Struct Mol Biol"},{"key":"77294_CR66","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1593\/neo.09706","volume":"11","author":"R Jiang","year":"2009","unstructured":"Jiang, R., Cabras, G., Sheng, W., Zeng, Y. & Ooka, T. Synergism of BARF1 with Ras induces malignant transformation in primary primate epithelial cells and human nasopharyngeal epithelial cells. Neoplasia11, 964\u2013973 (2009).","journal-title":"Neoplasia"},{"key":"77294_CR67","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.1128\/JVI.02301-07","volume":"82","author":"M Hsu","year":"2008","unstructured":"Hsu, M. et al. Epstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells. J Virol82, 3679\u20133688 (2008).","journal-title":"J Virol"},{"key":"77294_CR68","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/jmv.23208","volume":"84","author":"KR Katsumura","year":"2012","unstructured":"Katsumura, K. R., Maruo, S. & Takada, K. EBV lytic infection enhances transformation of B-lymphocytes infected with EBV in the presence of T-lymphocytes. J Med Virol84, 504\u2013510 (2012).","journal-title":"J Med Virol"},{"key":"77294_CR69","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/1097-0142(197602)37:2+<1014::AID-CNCR2820370805>3.0.CO;2-Z","volume":"37","author":"CC Harris","year":"1976","unstructured":"Harris, C. C. The carcinogenicity of anticancer drugs: a hazard in man. Cancer37, 1014\u20131023 (1976).","journal-title":"Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77294-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77294-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77294-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T21:19:45Z","timestamp":1731014385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77294-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,4]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["77294"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-77294-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,4]]},"assertion":[{"value":"2 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26694"}}